首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human CD274 Recombinant Antibody(Atezolizumab)

Anti-Human CD274 Recombinant Antibody(Atezolizumab)

产品编号

YR1354

别名

科研级 Atezolizumab ( 阿特利珠单抗 ), Anti-CD274 Recombinant Antibody, Research Grade Atezolizumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Atezolizumab ( 阿特利珠单抗 ), Anti-CD274 Recombinant Antibody, Research Grade Atezolizumab
Catalog NumberYR1354
Molecular NameAtezolizumab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1 Kappa
FormulationPBS, pH7.5
BackgroundAtezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), small cell lung cancer (SCLC), and hepatocellular carcinoma (HCC). It is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1).
CAS Number1380723-44-3
ApplicationELISA, IHC, IF, IP, FCM
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
Molecular Weight144.59 kDa
TargetCD274[Homo sapiens]

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价